Similar Items: An immunogenic cell death-based signature predicts prognosis and immune landscape in triple-negative breast cancer
- A machine-learning-derived multi-cell death mode signature predicts melanoma prognosis and reveals an immune-cold tumor microenvironment
- The adenosine A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implications
- Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)
- Integrated network pharmacology reveal new key curcumin-binding targets in triple-negative breast cancer
- A bibliometric analysis of global research trends in adoptive cell therapy for triple negative breast cancer over the past 15 years
- A novel mitochondrial-related gene signature for assessing the tumor immune microenvironment and predicting prognosis in human glioma